Supplemental conditionally essential nutrients in cardiovascular disease therapy.
Level 5 - mechanism / opinion, no new human data
Narrative review of clinical studies without systematic review methodology
PubMed 16407731 · doi:10.1097/00005082-200601000-00004
What was done
Narrative review evaluating the role and clinical evidence of conditionally essential nutrients (CENs) in cardiovascular disease (CVD) therapy. The review focuses primarily on controlled human studies of l-arginine, l-carnitine, propionyl-l-carnitine, and coenzyme Q10, while also noting taurine, alpha-lipoic acid, betaine, chondroitin sulfate, glutamine, and d-ribose.
What was found
The abstract reports no quantitative findings, effect sizes, confidence intervals, or patient counts. It qualitatively notes that CENs demonstrate favorable clinical effects across cardiovascular conditions, including chronic heart failure, myocardial infarction, angina pectoris, hypertension, hyperlipidemia, and elevated lipoprotein(a), with limited preliminary research on multi-nutrient combinations.
Why it matters
Highlights the therapeutic concept that organic compounds normally produced endogenously may become conditionally essential during cardiovascular pathology, warranting targeted supplementation.
Limits
The abstract provides no quantitative data, search protocol, study quality grading, or sample sizes. As a narrative review, it is prone to selection bias, and the authors note that additional controlled clinical trials are required to establish efficacy and optimal protocols.
Cited by
- context Administering a metabolic supplement cocktail including CoQ10, carnitine, creatine, ribose, alpha-lipoic acid, N-acetylcysteine, and B vitamins improves ejection fraction in heart failure patients.